U.S. cancer doctors to debate care costs

Jun 02, 2006

The American Society of Clinical Oncology's agenda at its Atlanta meeting includes a first time debate on cost-benefit analysis of cancer treatment.

This will be the first time the issue is coming to the fore in the United States where drugs often are allocated based on negotiations between healthcare providers, doctors and insurers, The Financial Times reported.

"In the not-too-distant future, our society will probably be looking more closely at the gains and costs for cancer treatments in the same ways that other therapies have been," Dr. Neal Merosol, the panel's chairman, told the newspaper.

The meeting traditionally has showcased developments in treatment and for marketing new drugs, while the costs of the drugs are not mentioned.

"ASCO needs to take a leadership role in helping to figure out how we can use resources to reward innovation so as to improve cancer treatments, while delivering high-quality care to all patients with cancer. But there is an antagonism between the two," said Merosol.

Copyright 2006 by United Press International

Explore further: New clinical trial launched for advance lung cancer

add to favorites email to friend print save as pdf

Related Stories

Kinesin-5 structure opens cancer drug targets

Apr 08, 2014

The structure of a key part of the machinery that allows cells to divide has been identified by researchers at the University of California, Davis—opening new possibilities for throwing a wrench in the machine and blocking ...

Nanoparticles cause cancer cells to self-destruct

Apr 03, 2014

Using magnetically controlled nanoparticles to force tumour cells to 'self-destruct' sounds like science fiction, but could be a future part of cancer treatment, according to research from Lund University ...

The promise and peril of nanotechnology

Mar 26, 2014

Scientists at Northwestern University have found a way to detect metastatic breast cancer by arranging strands of DNA into spherical shapes and using them to cover a tiny particle of gold, creating a "nano-flare" ...

Recommended for you

New clinical trial launched for advance lung cancer

9 minutes ago

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

User comments : 0

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

Simplicity is key to co-operative robots

A way of making hundreds—or even thousands—of tiny robots cluster to carry out tasks without using any memory or processing power has been developed by engineers at the University of Sheffield, UK.

Progress in the fight against quantum dissipation

(Phys.org) —Scientists at Yale have confirmed a 50-year-old, previously untested theoretical prediction in physics and improved the energy storage time of a quantum switch by several orders of magnitude. ...